Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic
1 clinical trials · Condition
◉ Watch Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic
| Record | Firm | Date |
|---|---|---|
| A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma (NCT02594384) | OrphAI Therapeutics | 2015-10-01 |
Track Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic automatically
Every clearance here is in the API, with alerts when new ones post.